Post Profile






Extending dosing intervals reduces deadly side effect risk from multiple sclerosis drug

A commonly-prescribed multiple sclerosis (MS) infusion medication linked to a rare but serious side effect is safer to use when dosing intervals are extended, according to a new study led by MS specialists NYU Langone Health.
read more

share

Related Posts


Experimental drugs that change energy supply in cells could slow brain tumor growth

Academics / General Science : Science Codex

Experimental drugs that alter cell metabolism also halted tumor growth and extended survival in mice with cancers linked to changes in the same gene, according to a new study led by researchers at NYU Langone Medical Center, its Lau...

What happens when multiple sclerosis patients stop taking their medication?

Academics / General Science : Science Codex

New research led by NYU Langone Medical Center examines what happens when a patient with multiple sclerosis (MS) who is clinically stable stops taking their medication. The international, multi-site study found almost 40 percent of ...

tDCS combined with computer games at home reduces cognitive symptoms of multiple sclerosis

Health : EurekAlert: Health

(NYU Langone Medical Center / New York University School of Medicine) Led by researchers at NYU Langone's Multiple Sclerosis Comprehensive Care Center, a new study reports that participants with multiple sclerosis who used tDCS whil...

Extending Treatment Up To Eight Weeks With Infusion Medication Shown Safe and Effective in Patients with Multiple Sclerosis

Health : Newswise Medical News

Extending the dose of an infusion medication for multiple sclerosis (MS), Natalizumab, from 4 weeks up to 8 has been shown to be well-tolerated and effective -- and resulted in no cases of the potentially fatal side effect, progress...

Extending dosing intervals reduces deadly side effect risk from multiple sclerosis drug

Health : EurekAlert: Health

(NYU Langone Health / NYU School of Medicine) A commonly-prescribed multiple sclerosis (MS) infusion medication, natalizumab, linked to a rare but serious side effect is safer to use when dosing intervals are extended, according to ...

Comments


Copyright © 2016 Regator, LLC